Small Molecules and Hematopoietic Stem Cells Presenter: Wang Lan.

Slides:



Advertisements
Similar presentations
Presented by Ke-Yong Shi StemEx ® from Research to Clinical Trial.
Advertisements

Discovery: Stem Cell Biology NIH Actions Continue infrastructure award program Characterize cell lines Stimulate more research on basic biology Train.
Microglia are tissue-resident macrophages in the CNS.
Research Techniques Made Simple: Identifying the Stem Cell Krisztian Nemeth, Sarolta Karpati Department of Dermatology, Venerology, and Dermatooncology,
Adult Stem Cells Stem Cells, Bone Marrow and Blood
Stem Cells: Roadmap to the clinic Negar Azarpira, MD Associate professor of Pathology 14 April 2010.
Retinoic Acid Receptor- Alpha and Its Role in Acute Promyelocytic Leukemia By Alex Sheng.
Targeted Therapies Against Lymphocyte Signaling Pathways in Childhood Leukemia Stuart S. Winter, MD Pediatric Hematology/Oncology The T. John Gribble Endowed.
Doug Brutlag 2011 Genomics, Bioinformatics & Medicine Doug Brutlag Professor Emeritus of.
ADULT STEM CELL DR ANDUJAR LPGN RESEARCH SCIENTIST.
Gene therapy progress and prospects cancer. Gene Therapy Primary challenge for gene therapy – Successfully delivery an efficacious dose of a therapeutic.
BIOT 412, Stem Cells, Ch. 12 December, Stem cells -Ability to renew themselves -Differentiate into diverse range of specialized cell.
Stem Cells. Learning Objectives SWBAT: Identify stem cells as ‘undifferentiated’ masses of cells. Explain how stem cells can become ‘specialized’ in a.
By Matthew Sampson. Overview What is it? Previous Treatments Monoclonal Antibodies Chimeric Molecules Oral Therapies Hematopoietic Stem Cells Future.
Findings Department of Health and Human Services National Institutes of Health National Institute of General Medical Sciences Mastering Stem Cells Molecular.
Stem cells and gene therapy to repair the damaged heart: will it work and is it right? John Martin Professor of Cardiovascular Medicine University College.
Gene therapy Fabrizia Urbinati 01/12/2010.
MiR-19b/20a/92a regulates the self- renewal and proliferation of gastric cancer stem cells Journal of Cell Science (IF=5.325) 报告人:黄美玲
Cell Specialization Remember..... All living things are made of cells!!! Cells can specialize into different cell types Cells  tissues  organs These.
Stem Cell Biology. Stem Cell The capacity of both self renewal and to generate differentiated progeny Byron Whites, US Supreme Court “ It’s hard to define,
Yeh-Chuin Poh Department of Mechanical Science and Engineering 5 th May 2011 Mechanical Force Effects on Cellular Functions May 2011.
Ibrutinib, Single Agent or in Combination with Dexamethasone, in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (MM): Preliminary Phase.
Role of gp130 Activation for HSC Self-renewal Aurore Degrange and Lisa Treat BE.400 Term Project December 10, 2002.
Personalized Lung Cancer Treatment: Targeting Stem Cell Pathways David M. Jablons, M.D. Professor and Chief Thoracic Surgery Ada Distinguished Professor.
What are Stem Cells Three general properties: they are capable of dividing themselves for long periods; they are unspecialized; and they can give rise.
Stem Cell Identification Nozad H. Stem cell workshop Stem cell Research center Tabriz medical university In The Name of God.
Overview of The Immune System:
Progress in Cancer Therapy Following Developments in Biopharma
Are all APL screated equal? Background image removed due to copyright considerations.
EnvironmentScaffolds Stem Cells Tissue Engineering & Regenerative Medicine.
Bmi-1 in Cancer Cancer genetics 2012/04/ 전종철
Society for Hematopathology/ European Association for Haematopathology 2013 Workshop Case 145 Nidhi Aggarwal, M.D.; Robert L. Redner, MD; Fiona E. Craig,
Hematopoietic Cancers Common Disruptions
CELL DIFFERENTIATION.
Stem Cells Lisheng WANG Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa.
Molecular Modeling in Drug Discovery: an Overview
Human umbilical cord primary cells Human umbilical cord blood mononuclear cells are isolated from umbilical cord blood. Human umbilical cord blood mononuclear.
(Donor T-Cells Transduced with iC9 Suicide Gene)
Discovery: Stem Cell Biology NIH Actions Continue infrastructure award program Characterize cell lines Stimulate more research on basic biology Train.
Cellular Differentiation
Mesenchymal Stem Cells: a new trend for cell therapy
Acceleration of Umbilical Cord Blood (UCB) Stem Engraftment: Results of a Phase I Clinical Trial with Stemregenin-1 (SR1) Expansion Culture  John E. Wagner,
Blood Development: Hematopoietic Stem Cell Dependence and Independence
Martin Wahlestedt, David Bryder  Cell Stem Cell 
Stem Cells.
Differential Effects of Epigenetic Modifiers on the Expansion and Maintenance of Human Cord Blood Stem/Progenitor Cells  Nadim Mahmud, Benjamin Petro,
Sources of Hematopoietic Stem and Progenitor Cells and Methods to Optimize Yields for Clinical Cell Therapy  Sandhya R. Panch, James Szymanski, Bipin.
Acceleration of Umbilical Cord Blood (UCB) Stem Engraftment: Results of a Phase I Clinical Trial with Stemregenin-1 (SR1) Expansion Culture  John E. Wagner,
Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction by Francesca.
Human CD4+CD25+ Cells in Combination with CD34+ Cells and Thymoglobulin to Prevent Anti-hematopoietic Stem Cell T Cell Alloreactivity  Dolores Mahmud,
Hematopoietic stem cell
Volume 8, Issue 4, Pages (April 2011)
Volume 17, Issue 3, Pages (September 2015)
Metabolic control of regulatory T cell development and function
Hematopoiesis from embryonic stem cells: lessons from and for ontogeny
Potential mechanisms of therapeutic synergy between epigenetic modulation and PD-1 pathway blockade. Potential mechanisms of therapeutic synergy between.
Kai Liu, Chen Yu, Min Xie, Ke Li, Sheng Ding  Cell Chemical Biology 
Managing Patients with Relapsed CLL who Discontinue BCR Signaling Inhibitors.
Volume 10, Issue 2, Pages (February 2012)
Ahmed Mohyeldin, Tomás Garzón-Muvdi, Alfredo Quiñones-Hinojosa 
Volume 4, Issue 2, Pages (February 2015)
A novel class I histone deacetylase inhibitor, I-7ab,
Blood Development: Hematopoietic Stem Cell Dependence and Independence
Volume 9, Issue 2, Pages (August 2011)
Fig. 1 HSCT: A platform for cellular therapies.
Fig. 1. In vivo fates of patient-derived AML cells defined by mutational profile. In vivo fates of patient-derived AML cells defined by mutational profile.
Stem cell Basics.
Evgenia V. Verovskaya, Paul V. Dellorusso, Emmanuelle Passegué 
Bone Marrow Niche Development of Hematopoietic Stem Cells
Presentation transcript:

Small Molecules and Hematopoietic Stem Cells Presenter: Wang Lan

Introduction Hematopoietic stem cells (HSCs): ▫Multipotent stem cells ▫Residing in the bone marrow ▫Self-renew and differentiate into all blood lineages Aggarwal R, Curr.Mol. Med, 2012, 12(1): 34-49

HSC Location during the Murine Embryonic Development Aggarwal R, Curr.Mol. Med, 2012, 12(1): 34-49

Widely used in transplantation therapies to treat blood disorders of different etiologies The major bottleneck: ▫The difficulty to obtain sufficient HSC numbers ▫Immunologically matched HSCs in the case of allogeneic transplantation

Walasek, MA, Ann. N.Y. Acad. Sci, 2012, 1266: HSC Self-Renewal Regulators

Small molecule drugs: ▫Better understanding of signaling pathways that control cell fate ▫Development of technologies for high-throughput screening ▫Regulation more flexible:  Temporal control the inhibition or activation  Finely tuned by delicately varying the concentrations or combinations Langle D, ACS Chem Biol, 2014, 9(1): 57-71

Small Compounds Screening Approaches Discovery-based chemical screens ▫Probes overall mechanisms ▫No requiring much of prior Knowledge of the targets being modulated Rationale-based chemical approach ▫Hypothesis-driven ▫Using mechanistically known small molecules Li W, ACS Cell Res, 2013, 23: 81-91

Walasek, MA, Ann. N.Y. Acad. Sci, 2012, 1266:

Copper Chelator, TEPA TEPA-supplemented, long-term cytokine cultures significantly increased the number of CD34+CD38- cells and enhanced NOD/SCID repopulating capacity. (Bae B, J.Nut, 1993) TEPA-cultured CB cells were coinfused with uncultured CB cells showed a safety of this approach in a phase I/II clinical trial. ( Peled T, Exp, Hematol, 2004; Peled T, Exp, Hematol, 2005 ) TEPA are under investigation in an ongoing phase II/III study. (Peled T, Cytotherapy, 2004; de Lima, Bone Marrow Transplant, 2008)

HSCs could be modulated through epigenetic regulation Histone Deacetylase Inhibitor, HDACi Valproic Acid Preserve the HSC phenotype for murine and human Chlamydocin Maintain hmPBHSC Trichostatin A Improve maintenance of stem cells in culture Upregulation of cell-intrinsic HSPC fate regulators, such as HoxB4 and AC133 Seet L, Eur. J. Haematol, 2009, 82: ; Araki H, Blood, 2009, 109: ; Milhem M, Blood, 2004, 103: ; Young JC, Cytotherapy, 2004, 6:

Acryl hydrocarbon receptor antagonist Enhances human CD34+ HSC cell amplification Potential mechanism: AhR on the surface of hHSC implicates in pathways regulating hematopoiesis StemRegenin 1, SR1 Boitano AE, Science, 2010, 329(5997):

Other Compounds All-trans Retinoic Acid (ATRA) 6-Bromoindirubin- 3’-Oxime (BIO) Prostaglandin E2 (PGE2) Promote HSC Expansion Regulate HSC Self-renewal Maintenance of HSC stemness Walasek, MA, Ann. N.Y. Acad. Sci, 2012, 1266: